| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |